The United States has suspended HIV funding to South Africa, a move that threatens the treatment of millions in the country with the world's largest HIV epidemic. In an abrupt shift, the Trump administration pulled the plug on the President's Emergency Plan for AIDS Relief (PEPFAR) programme, which provides antiretroviral drugs to 3.5 million South Africans. The decision, confirmed by the South African health ministry late Monday, has sent shockwaves through global health circles.
Within hours, the UK government announced a £2 billion pledge to help fill the void, channelled through the Global Fund to Fight AIDS, Tuberculosis and Malaria. The money will be disbursed over three years, targeting the hardest-hit regions. “The UK stands with South Africa in this crisis,” said International Development Secretary Andrew Mitchell, but critics question whether the pledge can truly replace the scale of US support.
For the workers and families on the ground, this is not a diplomatic chess game. In Soweto, community health worker Nomsa Zulu told me: “If the drugs stop, people will die. We have seen it before.” The US has been the backbone of HIV treatment here for two decades. The halt leaves clinics scrambling for supplies, with some fearing a return to the days when AIDS was a death sentence.
The UK’s commitment is welcome but comes with caveats. The government is already under pressure over cuts to domestic services, and Labour MPs have warned that overseas aid must not come at the expense of the NHS. “We cannot cure global ills while our own healthcare system is on its knees,” said Shadow Health Secretary Wes Streeting.
For now, the immediate impact on South Africa is stark. The UK pledge, if delivered, could keep patients on treatment, but only if the bureaucracy of the Global Fund moves faster than the virus. Every day the US funding is frozen, lives hang in the balance.